Preventing cardiac damage in patients with COVID-19

A cardiac organoid approach combined with phosphoproteomics and single nuclei RNA-sequencing identifies bromodomain and extraterminal family inhibitors as promising candidates to prevent COVID-19 mediated cardiac damage.

Detalles Bibliográficos
Autor principal: Robson, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025058/
https://www.ncbi.nlm.nih.gov/pubmed/33828252
http://dx.doi.org/10.1038/s41569-021-00550-3
Descripción
Sumario:A cardiac organoid approach combined with phosphoproteomics and single nuclei RNA-sequencing identifies bromodomain and extraterminal family inhibitors as promising candidates to prevent COVID-19 mediated cardiac damage.

Ejemplares similares